Inscription Capital’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.97M Buy
153,462
+53,820
+54% +$2.58M 0.71% 23
2026
Q1
$4.16M Buy
99,642
+62,100
+165% +$2.68M 0.44% 37
2025
Q4
$1.51M Buy
37,542
+5,892
+19% +$233K 0.15% 104
2025
Q3
$1.25M Buy
31,650
+1,550
+5% +$57.2K 0.13% 137
2025
Q2
$1.12M Buy
+30,100
New +$1.02M 0.16% 99

Other funds holding CPAI

Inscription Capital's CPAI Position: Q2 2026 in Review

Inscription Capital increased its Counterpoint Quantitative Equity ETF (CPAI) stake by 54% in Q2 2026, buying an estimated $2.58M and bringing the position to 153,462 shares worth $7.97M. The position accounts for 0.71% of the portfolio, ranked #23.

Inscription Capital first reported a position in CPAI in Q2 2025 and has held it in 5 quarters since. 54 funds tracked by Wall St. Rank hold CPAI as of Q2 2026.

  • Inscription Capital held 153,462 shares of Counterpoint Quantitative Equity ETF worth $7.97M as of Q2 2026.
  • Inscription Capital bought 53,820 Counterpoint Quantitative Equity ETF shares in Q2 2026, an estimated $2.58M.
  • Counterpoint Quantitative Equity ETF made up 0.71% of Inscription Capital's portfolio in Q2 2026, its #23 holding.
  • Inscription Capital first reported a position in Counterpoint Quantitative Equity ETF in Q2 2025 and has held it in 5 quarters since.
  • 54 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.